Health product recall

PMS-Zolmitriptan ODT (2020-02-26)

Starting date:
February 26, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-72463

Last updated: 2020-02-28

Summary

  • Product: PMS-Zolmitriptan ODT tablet

Reason

Out of specification result for impurity stability.

Depth of distribution

Wholesalers, Retailers

Affected products

PMS-Zolmitriptan ODT tablet

DIN, NPN, DIN-HIM

DIN 02324768

Dosage form

Tablet (Orally Disintegrating)

Strength

Zolmitriptan 2.5 mg

Lot or serial number

615992, 615993, 615994

Companies

Recalling Firm
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA

Pro Doc Zolmitriptan ODT (2020-02-26)

2020-02-26 | Health products

Recall

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: